Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Cancers|May 13, 2023
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328Helena Järemo, Julius Semenas, Sofia Halin Bergström, et al.
Scandinavian Journal of Urology|June 23, 2016
Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register studyJón Ö Fridriksson, Yasin Folkvaljon, Per Nilsson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 2, 2019
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 TrialBjørg Y Aksnessæther, Tor Åge Myklebust, Arne Solberg, et al.
Lancet (London, England)|December 19, 2008
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trialAnders Widmark, Olbjørn Klepp, Arne Solberg, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|May 22, 2018
Past and present work practices of European interventional cardiologists in the context of radiation protection of the eye lens-results of the EURALOC studyJoanna Domienik-Andrzejewska, Olivera Ciraj-Bjelac, Panagiotis Askounis, et al.
International Journal of Epidemiology|May 8, 2012
Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0Mieke Van Hemelrijck, Annette Wigertz, Fredrik Sandin, et al.
Clinical Genitourinary Cancer|September 11, 2016
Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA TrialNicholas J Vogelzang, Robert E Coleman, Jeff M Michalski, et al.
JNCI Cancer Spectrum|May 7, 2020
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort StudyAndreas Pettersson, Daniel Alm, Hans Garmo, et al.
Cancers|June 2, 2021
High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate CancerAnna-Maja Åberg, Sofia Halin Bergström, Elin Thysell, et al.
JAMA Oncology|May 26, 2018
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAndrew J Armstrong, Aseem Anand, Lars Edenbrandt, et al.
Pageof 10